Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

GE to buy Abbott’s in vitro diag units for $8.13 billion in cash

Jan. 25, 2007

By Amanda Pedersen

Deals roundup: Vision-Sciences will sell certain ENT assets for up to $34 million

Jan. 25, 2007

By Amanda Pedersen

Zeiss gets fast FDA clearance for its Visumax laser system

Jan. 24, 2007

By Amanda Pedersen

Changes in market push GE to buy Abbott’s lab diagnostics

Jan. 22, 2007

By Amanda Pedersen

Deals roundup: Iridex closes Laserscope deal for $26M and 214,000 shares

Jan. 19, 2007

By Amanda Pedersen

Onex buys Kodak’s Health Group in deal worth up to $2.55 billion

Jan. 18, 2007

By Amanda Pedersen

Vision-Sciences will sell certain ENT assets for up to $34 million

Jan. 18, 2007

By Amanda Pedersen

PMA opens ‘new ballgame’ for AngioScore in U.S. CAD market

Jan. 12, 2007

By Amanda Pedersen

Onex buys Kodak’s Health Group in deal worth up to $2.55 billion

Jan. 11, 2007

By Amanda Pedersen

NovaVision in $20M in Series C funding to back VRT marketing

Jan. 10, 2007

By Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...